Cigna Corporation (CI) Position Held by Mycio Wealth Partners LLC

Mycio Wealth Partners LLC maintained its stake in Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,150 shares of the health services provider’s stock at the end of the second quarter. Mycio Wealth Partners LLC’s holdings in Cigna Corporation were worth $1,047,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the stock. American Beacon Advisors Inc. bought a new stake in Cigna Corporation during the first quarter worth approximately $102,000. Founders Capital Management bought a new stake in Cigna Corporation during the first quarter worth approximately $117,000. Parallel Advisors LLC increased its stake in Cigna Corporation by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after buying an additional 307 shares in the last quarter. Mckinley Capital Management LLC Delaware bought a new stake in Cigna Corporation during the first quarter worth approximately $122,000. Finally, Guardian Life Insurance Co. of America increased its stake in Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares in the last quarter. Institutional investors and hedge funds own 87.61% of the company’s stock.

Cigna Corporation (NYSE:CI) traded down 0.26% on Friday, hitting $179.30. The stock had a trading volume of 844,421 shares. The company has a 50-day moving average price of $175.07 and a 200-day moving average price of $161.41. The stock has a market capitalization of $45.14 billion, a price-to-earnings ratio of 20.69 and a beta of 0.46. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $181.15.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. The company had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.98 earnings per share. Equities research analysts anticipate that Cigna Corporation will post $10.03 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was first published by [[site]] and is the sole property of of [[site]]. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at [[permalink]].

CI has been the subject of several recent analyst reports. UBS AG restated a “buy” rating and issued a $186.00 price target (up from $181.00) on shares of Cigna Corporation in a report on Monday, June 5th. Royal Bank Of Canada restated a “buy” rating and issued a $185.00 price target on shares of Cigna Corporation in a report on Wednesday, August 9th. Deutsche Bank AG increased their price target on Cigna Corporation from $180.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, August 7th. Zacks Investment Research downgraded Cigna Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, August 8th. Finally, Citigroup Inc. increased their price target on Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a report on Monday, August 7th. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $180.44.

In related news, CEO David Cordani sold 153,168 shares of the firm’s stock in a transaction that occurred on Monday, June 19th. The shares were sold at an average price of $170.20, for a total value of $26,069,193.60. Following the sale, the chief executive officer now owns 421,162 shares in the company, valued at $71,681,772.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Mary T. Hoeltzel sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $166.70, for a total transaction of $83,350.00. Following the completion of the sale, the vice president now owns 2,449 shares in the company, valued at approximately $408,248.30. The disclosure for this sale can be found here. Insiders have sold 232,008 shares of company stock valued at $39,828,200 in the last three months. 1.30% of the stock is owned by insiders.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).